Navigation Links
Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis

ANAHEIM, Calif., May 19, 2007 /PRNewswire/ -- Data presented today at a major medical meeting found that Levaquin (levofloxacin) 750 mg tablets administered once-daily for five days is as effective as standard therapy of ciprofloxacin (400/500 mg) for 10 days for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis (AP).

Ortho-McNeil, Inc., the company that markets LEVAQUIN in the U.S., presented the data during a scientific session at the annual meeting of the American Urological Association (AUA), held here this week.

Each year, urinary tract infections account for more than eight million physician visits. They occur in the kidneys, ureters, bladder or the urethra and often are recurrent, resulting in treatment with several courses of antibiotics. Complicated UTIs occur nearly as frequently in men as in women and often occur in people who are susceptible to bacterial infections because of a weakened immune system. Complicated UTIs also may be caused by structural or functional difficulties that interfere with the flow of urine, such as kidney stones.

Pyelonephritis is an infection of one or both kidneys caused by bacteria. It is estimated that more than 250,000 Americans suffer from AP every year, with 10 to 30 percent of cases resulting in hospitalization.

"A short course of five, once-daily doses of LEVAQUIN 750 mg is as effective as 10 twice-daily doses of ciprofloxacin in treating complicated urinary tract infections and acute pyelonephritis," said Norman R. Rosenthal, MD, Vice President, Medical Affairs, on behalf of Ortho-McNeil, Inc. "These findings will be important to the healthcare professionals that treat patients with these conditions."

The multi-center, double-blind, randomized study of 1,109 patients with either cUTI or AP was designed to assess the efficacy and safety of LEVAQUIN (750 mg QD/five days) versus ciprofloxacin (400/
'"/>




Page: 1 2 3 4

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
3. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
4. Gabapentin Shown Effective for Fibromyalgia Pain
5. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
6. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
7. XYOTAX More Cost Effective With Fewer Side Effects Than Gemcitabine or Vinorelbine in Treating Non-Small Cell Lung Cancer
8. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
9. Repeated Radioimmunotherapy With 131I-Labetuzumab Appears Safe and Effective in Colorectal Cancer with Liver Metastases
10. Biotheras Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study
11. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
Post Your Comments:
(Date:2/8/2010)... LOUIS , Feb. 8 Cost ... Healthcare Products (Nasdaq: AHPI ) narrowly back into ... ,, Sales for the quarter ended December 31, ... $12.5 million during the same quarter last year ... However, Allied,s costs of sales were reduced even more ...
(Date:2/8/2010)... EAST BRUNSWICK, N.J. , Feb. 8 /PRNewswire-FirstCall/ ... today that the company will release financial results for ... of the market on Thursday, February 25, 2010 ... David Gionco, Group Vice President and Chief Financial Officer, ... 10:00 a.m. Eastern Time on February ...
(Date:2/8/2010)... Feb. 8 Hanger Orthopedic Group, Inc. (NYSE: ... report its results of operations for the year ended ... . ,, The Company plans to issue a press release ... 2009 on Wednesday, February 10, 2010 , after ... to begin at 9:00 a.m., EST , on ...
Breaking Medicine Technology:Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2Hanger Orthopedic Group, Inc. Announces 2009 Year-End Earnings Release Conference Call 2New type of genetic change identified in inherited cancer 58828 1New type of genetic change identified in inherited cancer 58828 2New type of genetic change identified in inherited cancer 58828 3Study finds 231 new genes associated with head and neck cancer 10252 1Study finds 231 new genes associated with head and neck cancer 10252 21 Million Preemie Babies Die Each Year 3A Report 58826 11 Million Preemie Babies Die Each Year 3A Report 58826 21 Million Preemie Babies Die Each Year 3A Report 58826 3
... announced today the 28 recipients of the 2009 Seed Grant Research Program. ... physician residents and fellows to conduct basic science, applied or clinical research ... four categories: , , , ... HIV/AIDS , Leukemia , ...
... 6 B-R-A-H-M-S,Aktiengesellschaft today announced it has submitted ... (FDA) to market its patented B-R-A-H-M-S,MR-proANP Kryptor Test. ... (ANP) is predominantly produced in the atrium,of the ... in the,circulation. ANP is involved in natriuresis, diuresis, ...
Other Medicine Technology:AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3FDA Submission of B-R-A-H-M-S MR-proANP Kryptor 2
(Date:2/9/2010)... Center have found a direct link between neighborhood ... in African American women. The study, which appears ... , is the first prospective study to examine ... of type 2 diabetes in a large, geographically ... diabetes is estimated to affect 20.6 million people ...
(Date:2/9/2010)... Texas , Feb. 9 ... and project coordinator for the University of North ... Health Science Center , was instrumental in recently identifying ... in the Patio 29 cemetery. ,, The Chilean ... lead geneticist for a process audit team of the ...
(Date:2/9/2010)... most comprehensive study to date of secondhand smoke exposure ... journal Addiction . The study, carried out by ... reveals that exposure to household secondhand smoke among children ... researchers wanted to find out if there were ways ... children in private households, and whether those levels were ...
(Date:2/9/2010)... more effective in persuading young women to use birth ... according to a new study. , Researchers found that ... teen pregnancy felt more vulnerable two weeks after watching ... using birth control. , However, those who watched a ... were unmoved, and had no change in their intentions ...
(Date:2/9/2010)... 2010) AcademyHealth today recognized research that improves patient ... Services Research (HSR) Impact Award. The WHO Surgical ... ensure adherence to basic safety standards of care. ... that clearly translated into policy and, ultimately, made ... W. David Helms, Ph.D. "The WHO Surgical Safety ...
Breaking Medicine News(10 mins):Health News:Neighborhood socioeconomic status and diabetes 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 2Health News:UNT Health Science Center's Roby Helps Identify Bodies of Chile's Patio 29 3Health News:Exposure to secondhand smoke among children in England has declined since 1996 2Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:2010 HSR Impact Award recognizes surgical safety research 2
... Island College Hospital in Brooklyn is in news for the ... Long Island College Hospital are investigating the circumstances that led ... the wrong side of a patient’s brain to remove a ... as stable after a corrective surgery was conducted on the ...
... After waging wars over many drug formulations the pharma majors ... set in motion by the dramatic announcement of Indian firm ... less than a U.S. dollar a day. Not to be ... own production of anti retroviral drugs for AIDS treatment. , ...
... 7 months was the first recipient of a bloodless ... America. The seven month old, Aiden Michael Rush, whose ... to receive transfusions. The boy received 20% of his ... the children’s hospital in Los Angeles. , To avoid ...
... overcome a major obstacle to treating brain ailments such ... studies in rats, researchers from the Stroke Lab and ... “a direct path from the nose to the brain” ... from foreign substances, including drugs. Senior investigator Dr. ...
... The gay capital? of the world, San Francisco is now reeling ... In the past one-year the rate of infection has actually doubled ... men, who are also intra venous drug users, the rates are ... ,Hold your breath! The successful control of spread of HIV ...
... is a gift, exclusive to the blessed. The less ... problems such as early morning headaches or serious daytime ... its mild or moderate form is commonly experienced. Sleep ... breathing during sleep. Most individuals may have less severe ...
Other Medicine News:Health News:Nasal Spray Could Take Drugs Direct to Brain. 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: